Clinical Trials in North Carolina

Showing 1941-1960 of 9,731 trials

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

NCT02614547

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.

Severe Postpartum Depression

Supernus Pharmaceuticals, Inc.21 participantsStarted Dec 2015

Atlanta, Georgia, United States • Worcester, Massachusetts, United States • Chapel Hill, North Carolina, United States +1 more locations

COMPLETEDPhase 246 miles

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

NCT05107128

The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.

Huntington's Disease

Supernus Pharmaceuticals, Inc.189 participantsStarted Jan 2022

Little Rock, Arkansas, United States • La Jolla, California, United States • Los Angeles, California, United States +46 more locations

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)

Find Trials by Condition in North Carolina

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

BlueWind RENOVA iStim™ System for the Treatment of OAB

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

Omnipod 5 System Compared to Pump Therapy

Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Periprosthetic Fracture Registry (PPFx)

A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)